Are Probiotics Effective for UTI Prevention?

Urinary tract infections (UTIs) are common bacterial infections that affect the urinary tract system. If left untreated, it can lead to rising health expenses and severe health conditions such as kidney malfunction, sepsis, and abscess formation. Recurrent UTIs pose an inconvenience for many sufferers, especially women sufferers who may have to purchase OTC medications or request an antibiotic prescription from their primary physician to cope with the painful side effects. Despite OTC UTI treatment innovations, resolving a urinary tract infection can become challenging when confronted with antibiotic resistance or any severe side effects associated with over-the-counter medications. 

To successfully treat UTIs, adopting alternative treatment and prevention options has gained rising popularity. Experts often recommend incorporating vitamin supplements and probiotics into your daily self-care routine due to these supplements’ limited side effects and preventative abilities. For example, Uqora’s vitamin supplement line contains physician-tested ingredients to ensure they are user-friendly and effective in preventing UTIs. 

With the rise of probiotic therapy, it’s time we distance ourselves from standard rounds of antibiotics and research the success rates of probiotics for urinary tract health. Sick of enduring recurring bouts of painful urination and cramping, read on for more information on probiotics that prevent UTIs and restore comfort.

Can probiotics prevent UTIs?

Although you can quickly treat a UTI with antibiotics, this treatment method doesn’t deter recurrence. Antibiotics don’t provide your body with immunity against future infections. While a tried-and-true approach, the continued use of antibiotics not only causes resistance but may lead to the contraction of yeast infections among women.

In such a case, the use of probiotics comes in handy for an alternative preventive option. For those unfamiliar with preventative care for recurring UTIs, you may be wondering what probiotics are. They are live microorganisms vital for your body’s digestive system and digestive health.

It’s important to note that not all bacteria are destructive.  Your body contains several strains of good bacteria. Probiotics also consist of good bacteria that keep your digestive system healthy and ward off UTI-causing bacteria strains. You can derive these probiotics from foods such as yogurt, or you can purchase a supplement from your local health foods store. 

For those who doubt these tiny capsules’ UTI-fighting abilities, you may be wondering how effective probiotics are in preventing UTIs? There’s a lot of controversy surrounding whether or not probiotics can prevent UTIs. Many studies conducted, however inconclusive, indicate that probiotics like lactobacilli can help fight recurrent UTIs.

According to research, since lactobacilli are present in women who haven’t reached menopause, restoration of these bacteria in women experiencing recurrent UTIs establishes a healthy urinary tract system built to ward off infections. Researchers, however, have no scientific evidence of why the lack of lactobacilli is associated with UTIs. However, theories suggest that probiotics help the body fight off bacteria in the following ways:

  • Make the urine acidic, preventing the growth of bacteria
  • Prevent harmful bacteria from attaching to the urinary tract cells
  • Encourage the production of hydrogen peroxide, which prevents the growth of bacteria

It’s also worth noting that individuals who take lactobacillus supplement alongside antibiotics exhibit little resistance to those who choose not to incorporate a daily probiotic. Ultimately, these daily capsules are successful in their mission of preventing the contraction of urinary tract infections, as these probiotics inhibit the multiplication of resistant bacteria and replace harmful resistant bacteria with good bacteria.

Are probiotics good for me?

Probiotics are generally safe to use. Although, physicians should not prescribe these probiotics to those individuals at high risk of septicemia. Experts have conducted further studies to determine the optimal dosage and duration for taking probiotics. Unfortunately, research is inconclusive on the use of probiotics in older UTI sufferers. 

Conclusion

When opting for probiotics, remember that they don’t all contain the same series of ingredients. Choose the one with compounds necessary to boost your body’s immune system. For optimal results, you should also avoid probiotic supplements with starches and sweeteners, as they encourage the growth of pathogens in your gut. To be on the safe side, follow your doctor’s recommendations to purchase the correct probiotics supplement tailored to your unique health needs.

 

Hope for a New Way to Improve Quality of Life for ALS Patients

Dr. Sabrina Paganoni, M.D., Ph.D., Investigator at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Justin Klee, Co-Founder and Co-CEO of Amylyx Pharmaceuticals discuss ALS (amyotrophic lateral sclerosis or Lou Gerhig’s disease) and a new investigational treatment that has shown an ability for patients to retain function and independence longer.  The findings from that study are now being published in a leading medical journal. ALS as a disease has been notoriously challenging for new drug development, and this represents a historic step forward.

Read More

Biolog-id – Blood Products Supply Chain

Amit Mayer, VP of Innovation and Analytics at Biolog-id, a connected solutions company, discusses the current partnerships with blood product centers to provide real-time visibility of the blood supply, and the unique challenges of collecting, storing, and distributing blood products. He also talks about the impact Biolog-id’s technology has had on the efficiency of blood product collection, manufacturing, storage, and distribution.

Read More

VivaLNK Partners with Mazzetti For Remote Monitoring of COVID-19 Patients

Jiang Li, founder and CEO of VivaLNK, a provider of connected healthcare solutions discusses the partnership with Mazzeti, a provider of healthcare building systems engineering solutions. This collaboration allows pop-up facilities to be easily assembled and equipped with the technology needed to remotely monitor all patients.  VivaLNK’s reusable wearable medical sensors have been deployed in China at over 15 hospitals throughout the COVID-19 outbreak, and are now available throughout the U.S. to continuously monitor patient temperature, heart rate, and respiratory rate, sending data wirelessly via Bluetooth to the respective caregivers to monitor and respond accordingly.

Read More

FDA Approval of LYNPARZA® in US for HRR gene-mutated mCRPC

Dr. Josefa Briceno, M.D., Medical Head for the DNA Damage Response Franchise in US Medical Affairs at AstraZeneca discusses the recent FDA approval of LYNPARZA® (olaparib) for the treatment of adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with enzalutamide or abiraterone.  Approval was based on results from the Phase III PROfound trial, which were published in the “New England Journal of Medicine”.

Read More

FDA Approval of Enspryng™ For Neuromyelitis Optica Spectrum Disorder (NMOSD)

Dr. Geoffrey Eubank, M.D., Medical Director of the Mid Ohio MS Center at OhioHealth Neurological Physicians, discusses 2 Phase lll clinical trials of Enspryng™ (satralizumab-mwge) that demonstrated robust efficacy and safety profiles for the treatment of adults living with anti-aquaporin-4 (AQP4) antibody-positive NMOSD, a rare disabling neurological disorder often misdiagnosed as multiple sclerosis.  Enspryng represents significant therapeutic progress for the NMOSD community, offering the only FDA-approved injectable treatment option that can be self-administered every four weeks by a person living with NMOSD or a caregiver following training from a healthcare provider. 

Read More

Aegis Life’s Investigational DNA Vaccine

Dr. John Lewis, Ph.D., CEO of Aegis Life, Inc., a spinout of Entos Pharmaceuticals, discusses the company’s goal of developing a novel DNA vaccine using its proprietary gene delivery technology, Fusogenix, in the fight against COVID-19.  The flexibility of Fusogenix may enable Aegis Life’s investigational DNA vaccine to target and deliver simultaneously the Spike (S) protein and the Nucleocapsid (N) protein intracellularly. This approach may maximize the potential of inducing a potent, durable, and balanced T cell response against COVID-19, in addition to having a strong neutralizing antibody response.

Read More